Atomic structure of a rationally engineered gene delivery vector, AAV2.5

被引:20
|
作者
Burg, Matthew [1 ]
Rosebrough, Claire [1 ]
Drouin, Lauren M. [1 ,6 ]
Bennett, Antonette [1 ]
Mietzsch, Mario [1 ]
Chipman, Paul [1 ]
McKenna, Robert [1 ]
Sousa, Duncan [2 ]
Potter, Mark [3 ,4 ]
Byrne, Barry [3 ,4 ]
Samulski, R. Jude [5 ]
Agbandje-McKenna, Mavis [1 ]
机构
[1] Univ Florida, Coll Med, Dept Biochem & Mol Biol, McKnight Brain Inst, Gainesville, FL 32610 USA
[2] Florida State Univ, Dept Biol Sci, Biol Sci Imaging Resource, 89 Chieftan Way,Rm 119, Tallahassee, FL 32306 USA
[3] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[5] Univ N Carolina, Dept Pharmacol, Gene Therapy Ctr, Chapel Hill, NC 27515 USA
[6] Voyager Therapeut Inc, Cambridge, MA USA
关键词
Adeno-associated virus; cryo-EM; Vector engineering; Structure-guided design; Parvovirus; THERAPY; TRANSDUCTION; INSIGHTS; BINDING; CELLS; MODEL;
D O I
10.1016/j.jsb.2018.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AAV2.5 represents the first structure-guided in-silica designed Adeno-associated virus (AAV) gene delivery vector. This engineered vector combined the receptor attachment properties of AAV serotype 2 (AAV2) with the muscle tropic properties of AAV1, and exhibited an antibody escape phenotype because of a modified antigenic epitope. To confirm the design, the structure of the vector was determined to a resolution of 2.78 angstrom using cryo-electron microscopy and image reconstruction. The structure of the major viral protein (VP), VP3, was ordered from residue 219 to 736, as reported for other AAV structures, and the five AAV2.5 residues exchanged from AAV2 to AAV1, Q263A, T265 (insertion), N706A, V709A, and T717N, were readily interpretable. Significantly, the surface loops containing these residues adopt the AAV1 conformation indicating the importance of amino acid residues in dictating VP structure.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 50 条
  • [1] Rationally Engineered Novel AAV Capsids for Intraarticular Gene Delivery
    Li, Wenjun
    Samulski, R. Jude
    Li, Chengwen
    MOLECULAR THERAPY, 2023, 31 (04) : 651 - 652
  • [2] Rationally Engineered AAV Variants for Efficient Gene Delivery to Muscle
    Sin, Philip C.
    Hu, Hanyang
    Du, Zengmin
    Li, Dandan
    Wu, Shihao
    Xue, Huaqing
    Jiang, Wei
    Wu, Xia
    Zheng, Jane
    Xiao, Xiao
    MOLECULAR THERAPY, 2024, 32 (04) : 264 - 264
  • [3] Rationally engineered novel AAV capsids for intra-articular gene delivery
    Li, Wenjun
    Feng, Susi Liu
    Herrschaft, Lizette
    Samulski, R. Jude
    Li, Chengwen
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [4] Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
    Lompre, A-M
    Hadri, L.
    Merlet, E.
    Keuylian, Z.
    Mougenot, N.
    Karakikes, I.
    Chen, J.
    Atassi, F.
    Marchand, A.
    Blaise, R.
    Limon, I.
    McPhee, S. W. J.
    Samulski, R. J.
    Hajjar, R. J.
    Lipskaia, L.
    GENE THERAPY, 2013, 20 (09) : 901 - 912
  • [5] Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
    A-M Lompré
    L Hadri
    E Merlet
    Z Keuylian
    N Mougenot
    I Karakikes
    J Chen
    F Atassi
    A Marchand
    R Blaise
    I Limon
    S W J McPhee
    R J Samulski
    R J Hajjar
    L Lipskaia
    Gene Therapy, 2013, 20 : 901 - 912
  • [6] Rationally Designed a Novel AAV Capsid for Intra-Articular Gene Delivery
    Luo, Shuang
    Xie, Qing
    Li, Qingwei
    Zheng, Qiang
    MOLECULAR THERAPY, 2024, 32 (04) : 263 - 263
  • [7] Characterization of Novel AAV Vectors Engineered for Muscle Gene Delivery
    Green, Jennifer
    Golebiowski, Diane
    Willacy, Tiffany
    Huang, Guanrong
    Soustek-Kramer, Meghan
    Nguyen, Paul
    Anderson, Sara
    Hornakova, Alena
    McGonigle, Sharon
    Morris, Carl
    Pechan, Peter
    MOLECULAR THERAPY, 2020, 28 (04) : 247 - 247
  • [8] A Novel Rationally Designed AAV Capsid Yields a Potent Neurotropic Gene Therapy Vector
    Henckaerts, Els
    Tordo, Julie
    Palomar, Nuria
    Rahman, Jahedur
    Aldrin-Kirk, Patrick
    Basche, Mark
    Bennett, Antonette
    O'Leary, Claire
    Ali, Robin
    Agbandje-McKenna, Mavis
    Bigger, Brian
    Rahim, Ahad A.
    Bjorklund, Tomas
    Waddington, Simon
    Linden, R. Michael
    MOLECULAR THERAPY, 2016, 24 : S101 - S101
  • [9] Chemically-Engineered AAV Vectors: How Chemistry Improves AAV Liver Gene Delivery
    Lalys, Pierre-Alban
    Bouzelha, Mohammed
    Pavageau, Karine
    Alvarez-Dorta, Dimitri
    Bourdon, Audrey
    Gouin, Sebastien
    Jaulin, Nicolas
    Guilbaud, Mickael
    Le Guiner, Caroline
    Adjali, Oumeya
    Deniaud, David
    Mevel, Mathieu
    MOLECULAR THERAPY, 2022, 30 (04) : 70 - 70
  • [10] A hybrid phage-AAV vector for gene delivery and imaging
    不详
    CANCER BIOLOGY & THERAPY, 2006, 5 (05) : 459 - 460